Cargando…
Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line
Glycyrrhizin (GL) is known to have various immunomodulating activities and has long been used clinically as an anti-allergic and anti-hepatitis agent. While the potency of GL against lung inflammatory diseases has been expected, the effect of GL on the lung has been poorly understood. Lung fibroblas...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106177/ https://www.ncbi.nlm.nih.gov/pubmed/15454116 http://dx.doi.org/10.1016/j.intimp.2004.07.023 |
_version_ | 1783512562758844416 |
---|---|
author | Matsui, Sachiko Matsumoto, Hiroatsu Sonoda, Yoshiko Ando, Kumi Aizu-Yokota, Eriko Sato, Toshitsugu Kasahara, Tadashi |
author_facet | Matsui, Sachiko Matsumoto, Hiroatsu Sonoda, Yoshiko Ando, Kumi Aizu-Yokota, Eriko Sato, Toshitsugu Kasahara, Tadashi |
author_sort | Matsui, Sachiko |
collection | PubMed |
description | Glycyrrhizin (GL) is known to have various immunomodulating activities and has long been used clinically as an anti-allergic and anti-hepatitis agent. While the potency of GL against lung inflammatory diseases has been expected, the effect of GL on the lung has been poorly understood. Lung fibroblasts are known as a potent producer of inflammatory chemokines, IL-8 and eotaxin 1, by which neutrophils and eosinophils are strongly attracted during inflammation. Therefore, we studied the effects of GL on the production of these chemokines using a human fetal lung fibroblast cell line, HFL-1, stimulated with TNF-α and IL-4. Moreover, we examined the structure–activity relationships of GL to explore more beneficial compounds. 18α,β-GL inhibited IL-8 dose-dependently and inhibited eotaxin 1 slightly. 18α,β-Glycyrrhetic acid (GA) did not inhibit IL-8 but inhibited eotaxin 1. The effect of 18α,β-glycyrrhetic acid monoglucuronide (MGA) resembled that of 18α,β-GL but was weaker. Both 3β-[(2-O-β-d-glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-18β-11-deoxo-olean-12-en-30-oic acid (11-deoxo-GL) and 3β-[(2-O-β-d-glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-olean-11,13,(18)-dien-30-oic acid (hetero-GL) exhibited inhibitory activity with significant cytotoxicity. 3β-[(2-O-β-d-Glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-18β-olean-9,12-dien-30-oic acid (homo-GL) did not have cytotoxicity but its activity was mild like that of 18α,β-GL. 3β-[(2-O-β-d-Glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-olean-11,13(18)-dien-30-ol (hetero-30-OH-GL) and 3β-[(2-O-β-d-glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-18β-olean-9,12-dien-30-ol (homo-30-OH-GL) showed potent inhibitory effects, at concentrations lower than 18α,β-GL with no significant cytotoxicity. These results suggest that GL-related compounds are effective in reducing chemokine production and that GL-modified compounds including hetero-30-OH-GL and homo-30-OH-GL appear most beneficial in view of their inhibitory capacity with less cytotoxicity. |
format | Online Article Text |
id | pubmed-7106177 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71061772020-03-31 Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line Matsui, Sachiko Matsumoto, Hiroatsu Sonoda, Yoshiko Ando, Kumi Aizu-Yokota, Eriko Sato, Toshitsugu Kasahara, Tadashi Int Immunopharmacol Article Glycyrrhizin (GL) is known to have various immunomodulating activities and has long been used clinically as an anti-allergic and anti-hepatitis agent. While the potency of GL against lung inflammatory diseases has been expected, the effect of GL on the lung has been poorly understood. Lung fibroblasts are known as a potent producer of inflammatory chemokines, IL-8 and eotaxin 1, by which neutrophils and eosinophils are strongly attracted during inflammation. Therefore, we studied the effects of GL on the production of these chemokines using a human fetal lung fibroblast cell line, HFL-1, stimulated with TNF-α and IL-4. Moreover, we examined the structure–activity relationships of GL to explore more beneficial compounds. 18α,β-GL inhibited IL-8 dose-dependently and inhibited eotaxin 1 slightly. 18α,β-Glycyrrhetic acid (GA) did not inhibit IL-8 but inhibited eotaxin 1. The effect of 18α,β-glycyrrhetic acid monoglucuronide (MGA) resembled that of 18α,β-GL but was weaker. Both 3β-[(2-O-β-d-glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-18β-11-deoxo-olean-12-en-30-oic acid (11-deoxo-GL) and 3β-[(2-O-β-d-glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-olean-11,13,(18)-dien-30-oic acid (hetero-GL) exhibited inhibitory activity with significant cytotoxicity. 3β-[(2-O-β-d-Glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-18β-olean-9,12-dien-30-oic acid (homo-GL) did not have cytotoxicity but its activity was mild like that of 18α,β-GL. 3β-[(2-O-β-d-Glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-olean-11,13(18)-dien-30-ol (hetero-30-OH-GL) and 3β-[(2-O-β-d-glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-18β-olean-9,12-dien-30-ol (homo-30-OH-GL) showed potent inhibitory effects, at concentrations lower than 18α,β-GL with no significant cytotoxicity. These results suggest that GL-related compounds are effective in reducing chemokine production and that GL-modified compounds including hetero-30-OH-GL and homo-30-OH-GL appear most beneficial in view of their inhibitory capacity with less cytotoxicity. Elsevier B.V. 2004 2004-08-23 /pmc/articles/PMC7106177/ /pubmed/15454116 http://dx.doi.org/10.1016/j.intimp.2004.07.023 Text en Copyright © 2004 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Matsui, Sachiko Matsumoto, Hiroatsu Sonoda, Yoshiko Ando, Kumi Aizu-Yokota, Eriko Sato, Toshitsugu Kasahara, Tadashi Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line |
title | Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line |
title_full | Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line |
title_fullStr | Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line |
title_full_unstemmed | Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line |
title_short | Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line |
title_sort | glycyrrhizin and related compounds down-regulate production of inflammatory chemokines il-8 and eotaxin 1 in a human lung fibroblast cell line |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106177/ https://www.ncbi.nlm.nih.gov/pubmed/15454116 http://dx.doi.org/10.1016/j.intimp.2004.07.023 |
work_keys_str_mv | AT matsuisachiko glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline AT matsumotohiroatsu glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline AT sonodayoshiko glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline AT andokumi glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline AT aizuyokotaeriko glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline AT satotoshitsugu glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline AT kasaharatadashi glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline |